Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease

Archives of Neurology

Volumn 58, Issue 10, 2001, Pages 1660-1668

  De Marcaida, J A ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; REMACEMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HUMAN; LANG FAHN ACTIVITIES OF DAILY LIVING DYSKINESIA SCALE; LONG TERM CARE; MALE; MODIFIED GOETZ DYSKINESIA RATING SCALE; MULTICENTER STUDY; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SELF REPORT;

EID: 0034793204     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.10.1660     Document Type: Article

References (26)

1. Motor complications of chronic levodopa therapy in Parkinson's disease
2. Classification of fluctuations in patients with Parkinson's disease
3. Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part I
4. Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
5. Pathogenesis of dyskinesias in Parkinson's disease
6. Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys
7. Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease
8. Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications
9. Motor fluctuations in levodopatreated parkinsonian rats: Relation to lesion extent and treatment duration
10. NMDA receptor blockade reverses motor response alterations induced by levodopa
11. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits
12. Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits effects of dopaminergic denervation and L-DOPA administration
13. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease
14. A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for Parkinson's disease
15. A randomized controlled trial of remacemide for motor fluctuations in Parkinson's disease
16. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease
17. Utility of an objective dykinesia rating scale for Parkinson's disease: Inter- and intratater reliability assessment
18. Core Assessment Program for Intracerebral Transplantations (CAPIT)
19. Core Assessment Program for Intracerebral Transplantations (CAPIT)
20. A Unified Dyskinesias Rating Scale for 1-dopa-induced dyskinesias?
21. Unified Parkinson's Disease Rating Scale
22. ECDEU Assessment Manual for Psychopharmacology
23. "On-off" phenomenon with levodopa therapy in parkinsonism: Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine
24. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: Preliminary observations
25. Levodopa-induced dyskinesia: Review, observations, and speculations